Cellecta provides HT RNAi-based genetic screening services for the discovery and functional characterization of novel therapeutic targets. We offer pooled lentiviral shRNA libraries, shRNA library screening and analysis by HT sequencing, individual lentiviral expression constructs, and stable reporter, overexpression, or knockdown constructs and cell lines.